September 2018

The Firm’s Aircraft Finance and Securities Practice Expands with the Addition of Partner Tsuguhito Omagari

Sonderhoff & Einsel welcomes Tsuguhito Omagari as a partner in the Law practice of the firm.  Tsuguhito has a diverse background as a finance/corporate partner who has been practicing law for over 15 years.


After graduating from University of Tokyo and the Legal Training and Research Institute, Tsugu began working at the Tokyo office of a Magic Circle UK law firm where he focused on banking and finance and corporate M&A transactions.  During his career at the UK law firm, he also had the privilege of working out of the firm’s London and Hong Kong offices as well as being provided the opportunity to obtain his LLM from the University of Pennsylvania Law School and his New York State Bar license.  He also has the experience of being seconded to a Japanese bank and a Japan office of a French cosmetics company.


In 2011, he joined the Tokyo office of a large US-based global law firm where he advised on domestic and cross-border transactions and focused on banking, asset finance (especially aircraft finance and real estate finance), and securities matters.


“I am very excited to be here and work with a number of talented professionals in various areas, which should definitely expand my practice and knowledge.   I would like to make as much contribution as possible to the firm” said Tsugu.  With our firm’s growing aircraft finance practice, we look forward to working with Tsugu to take our aircraft finance practice to the next level.


In his free time, Tsugu likes to take a jog along with the Arakawa River as well as spend time with his 4 children.

Continue Reading

On August 30th, 2018 an event entitled “From the Ground Up: The Latest IP Information Related to Pharmaceutical Patents such as the China/Taiwan Patent Linkage System”

Sonderhoff & Einsel’s patent attorneys, Xiaofen Wu , Hiroshi Morita, and attorney-at-law, Ayuko Nemoto, gave a seminar on IP in China and Taiwan, which was held by Johokiko Co., Ltd. Currently, legal systems regarding the management of pharmaceuticals are taking shape in China and Taiwan and patent strategies for pharmaceuticals are playing an important role in companies’ business plans. In particular, the obtainment and exercise of patent rights heavily influence the profitability of these companies, and it has become crucially important to have a thorough understanding of such related matters.


Against this background, the seminar focused on the rapidly developing situation in China and Taiwan and the latest IP information related to pharmaceutical patents, such as the recent trends in the Chinese legal system and changes to the organization of the State Council (of the PRC), the China/Taiwan Patent Linkage System, generic drug development/filing and their relationship to patent rights, actual examples of patent management related to petitions for the filing of generic drugs made by Chinese firms, patent right infringement litigation in the Chinese pharmaceutical Industry and the Taiwan Pharmaceutical Patent Linkage System were discussed. In addition, Ms. Wu, Mr. Morita, and Ms. Nemoto introduced examples of recent decisions by the Supreme Court of the PRC as they relate to patent requirements for pharmaceutical patents and the interpretation of rights, and also explained certain points to keep in mind regarding the conduct of related business.

Continue Reading